Treatment perspectives in advanced non-small cell lung cancer.
Soto Parra
H
H
Department of Medical Oncology and Hematology, Istituto Clinico Humanitas, Rozzano, Mi. hector.sotoparra@humanitas.it
Latteri
F
F
Cavina
R
R
Sala
A
A
Dambrosio
M
M
Alloisio
M
M
Santoro
A
A
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D015687:Cell Hypoxia; D005492:Folic Acid / Q000187:drug effects; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000517:prevention & control; D009944:Organoplatinum Compounds / Q000627:therapeutic use; D000077150:Oxaliplatin; D015398:Signal Transduction / Q000187:drug effects
D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D005492:Folic Acid